First Mercantile Trust’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,845
| Closed | -$50K | – | 966 |
|
|
2020
Q1 | $50K | Sell |
4,845
-34
| -0.7% | -$351 | 0.01% | 704 |
|
|
2019
Q4 | $80K | Sell |
4,879
-81
| -2% | -$1.33K | 0.01% | 731 |
|
|
2019
Q3 | $66K | Buy |
4,960
+516
| +12% | +$6.87K | 0.01% | 773 |
|
|
2019
Q2 | $63K | Buy |
4,444
+84
| +2% | +$1.19K | 0.01% | 734 |
|
|
2019
Q1 | $80K | Sell |
4,360
-750
| -15% | -$13.8K | 0.02% | 718 |
|
|
2018
Q4 | $134K | Sell |
5,110
-890
| -15% | -$23.3K | 0.03% | 555 |
|
|
2018
Q3 | $138K | Sell |
6,000
-1,195
| -17% | -$27.5K | 0.03% | 615 |
|
|
2018
Q2 | $137K | Buy |
7,195
+335
| +5% | +$6.38K | 0.03% | 622 |
|
|
2018
Q1 | $116K | Hold |
6,860
| – | – | 0.02% | 648 |
|
|
2017
Q4 | $104K | Buy |
6,860
+880
| +15% | +$13.3K | 0.02% | 706 |
|
|
2017
Q3 | $107K | Sell |
5,980
-50
| -0.8% | -$895 | 0.02% | 706 |
|
|
2017
Q2 | $98K | Sell |
6,030
-100
| -2% | -$1.63K | 0.02% | 732 |
|
|
2017
Q1 | $86K | Sell |
6,130
-360
| -6% | -$5.05K | 0.01% | 761 |
|
|
2016
Q4 | $104K | Buy |
6,490
+70
| +1% | +$1.12K | 0.02% | 746 |
|
|
2016
Q3 | $107K | Sell |
6,420
-2,440
| -28% | -$40.7K | 0.01% | 711 |
|
|
2016
Q2 | $99K | Sell |
8,860
-290
| -3% | -$3.24K | 0.01% | 740 |
|
|
2016
Q1 | $76K | Sell |
9,150
-300
| -3% | -$2.49K | 0.01% | 791 |
|
|
2015
Q4 | $88K | Buy |
9,450
+240
| +3% | +$2.24K | 0.01% | 843 |
|
|
2015
Q3 | $104K | Buy |
9,210
+1,620
| +21% | +$18.3K | 0.01% | 813 |
|
|
2015
Q2 | $96K | Sell |
7,590
-110
| -1% | -$1.39K | 0.01% | 878 |
|
|
2015
Q1 | $72K | Buy |
+7,700
| New | +$72K | 0.01% | 910 |
|
|
2014
Q3 | – | Sell |
-3,505
| Closed | -$57K | – | 1205 |
|
|
2014
Q2 | $57K | Buy |
+3,505
| New | +$57K | ﹤0.01% | 928 |
|